immunity News and Research

RSS

GCS centers support research to fight against global COVID-19 pandemic

In December 2019, the world learned of a new and deadly pathogen. News coming out of Wuhan, China confirmed public health experts' worst fears--a novel coronavirus appeared to have jumped from animals to humans.

11 May 2020

New HIV vaccine better at preventing infection and offers more durable protection

Researchers from the Emory Consortium for Innovative AIDS Research in Nonhuman Primates and their colleagues across North America have shown a new HIV vaccine is better at preventing infection and lasts longer, continuing to protect one year after vaccination.

11 May 2020

Researchers launch antibody test to understand COVID-19 immunity

University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means.

11 May 2020

New initiative to deliver immune support saves lives of frontline NHS staff

The new Frontline Immune Support Team has been founded to provide quality, free immune support to frontline NHS staff risking their lives in the struggle to combat the Covid-19 pandemic.

11 May 2020

Reproduction number of COVID-19 and how it relates to public health measures

A new study published on the preprint server medRxiv in May 2020 reports the use of a dynamic SEIR model to identify variations in the reproductive number of SARS-CoV-2 over time, using machine learning techniques. This could help to model and predict the outcomes of various public health solutions.

10 May 2020

Reproduction number and herd immunity in COVID-19

A new modeling study published on the preprint server medRxiv* in May 2020 hypothesizes that the asymptomatic cases in the ongoing pandemic in Japan may far outnumber the symptomatic infections by several orders of magnitude. This has implications for future predictions and public health policies.

10 May 2020

Study demonstrates dynamic and broad-scale immune alterations in COVID-19 patient

A new case report released on the preprint server medRxiv* provides a detailed longitudinal analysis of the immune response associated with a fatal case of coronavirus disease (COVID-19). It highlights the need for addressing the source of hyper inflammation in the treatment approach.

10 May 2020

Researchers discover new type of antigen-presenting immune cell

With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell.

8 May 2020

Researchers discover molecular mechanism that helps HSV1 infect the brain

Herpes simplex virus (HSV1) infections are initiated at mucosal surfaces where the virus infects epithelial cells.

8 May 2020

Study sheds light on how a cellular pathway in plants senses danger signals

In nature, every species must be equipped with a strategy to be able to survive in response to danger. Plants, too, have innate systems that are triggered in response to a particular threat, such as insects feeding on them.

8 May 2020

The nutritional key to control autoimmunity and cancer

Scientists at the Department of Infection and Immunity of the Luxembourg Institute of Health revealed a novel mechanism through which the immune system can control autoimmunity and cancer.

8 May 2020

Intervention strategy based on shield immunity could reduce risk of expanding economic activity

While attention remains focused on the number of COVID-19 deaths and new cases, a separate statistic - the number of recovered patients - may be equally important to the goal of minimizing the pandemic's infection rate as shelter-in-place orders are lifted.

8 May 2020

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology today.

8 May 2020

Children are immune prepared for SARS-CoV-2

At least 30 new diseases have emerged in the last 20 years and now together threaten the health of hundreds of millions of people. For many of these diseases, there is no treatment, cure, or vaccine. While most of these diseases are dangerous to children, especially those younger than five years old, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to spare most of them.

8 May 2020

SARS-CoV-2 found in semen of COVID-19 patients

Since the novel coronavirus, now called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019, viral loads have been detected in body fluids, such as urine samples, saliva, stool samples, and in the gastrointestinal tract. Now, a new study reveals the SARS-CoV-2 virus in semen.

7 May 2020

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

The human gut microbiota consists of trillions of bacteria, fungi and virus constituting an inner chemical factory producing a multitude of microbial compounds affecting immunity, neurobiology and metabolism of the human host.

7 May 2020

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Arrayjet Limited, the Scottish-based bio-printing technology specialist for the life sciences industry, has re-purposed its in-house antibody screening technology to create a population-scale diagnostic program that will help scientists better understand the behavior of the Covid-19 virus and further the rapidity of a global vaccination program.

7 May 2020

Low CD8 and NK cell counts in the lung linked to high SARS-CoV-2 ACE2 receptor levels

A new study published on the preprint server bioRxiv in April 2020 reports that low levels of specific immune cells, namely, CD8 T cells and NK cells, are linked to higher expression of the ACE2 molecule, which acts as a receptor for the CoV.

6 May 2020

COVID-19 infection risk and outcomes explained by the cell receptor genetic variability

Genetic variants in the angiotensin‐converting enzyme 2 (ACE2) receptor, utilized by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) for cell entry, are predicted to either encourage or inhibit interaction with viral proteins and subsequently contribute to genetic risk in coronavirus disease (COVID-19). This is the key finding of a new study available on the preprint server bioRxiv*.

5 May 2020

Patients recently recovered from COVID-19 produce virus-specific antibodies

Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same.

5 May 2020

immunity News and Research

GCS centers support research to fight against global COVID-19 pandemic

New HIV vaccine better at preventing infection and offers more durable protection

Researchers launch antibody test to understand COVID-19 immunity

New initiative to deliver immune support saves lives of frontline NHS staff

Reproduction number of COVID-19 and how it relates to public health measures

Reproduction number and herd immunity in COVID-19

Study demonstrates dynamic and broad-scale immune alterations in COVID-19 patient

Researchers discover new type of antigen-presenting immune cell

Researchers discover molecular mechanism that helps HSV1 infect the brain

Study sheds light on how a cellular pathway in plants senses danger signals

The nutritional key to control autoimmunity and cancer

Intervention strategy based on shield immunity could reduce risk of expanding economic activity

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Children are immune prepared for SARS-CoV-2

SARS-CoV-2 found in semen of COVID-19 patients

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Low CD8 and NK cell counts in the lung linked to high SARS-CoV-2 ACE2 receptor levels

COVID-19 infection risk and outcomes explained by the cell receptor genetic variability

Patients recently recovered from COVID-19 produce virus-specific antibodies

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News